MEIP
insider transactionsMEI Pharma, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
-608.5K
82.1K buy · 690.6K sell
Net value · 365d
-$825.4K
$120.7K in · $946.1K out
Sentiment · 365d
Net selling
11% buying · 89% selling
Open-market trades · 365d
3
82.1K buy · 690.6K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
File Justin J. KEY
CEO, CFO and Secretary
—
455.0K sh
Own +253%
-
Buy·P
Director
$98.0K
70.0K sh · $1.40
Own +233%
-
Sell·S
TenPercentOwner
$946.1K
690.6K sh · $1.37
Own -16%
-
Buy·P
Director
$22.7K
12.1K sh · $1.88
Own +68%
-
Grant·A
File Justin J. KEY
CEO, CFO and Secretary
—
635.0K sh
Own New
-
Grant·A
Director
—
55.0K sh
Own New
-
Grant·A
Director
—
55.0K sh
Own New
-
Grant·A
Director
—
10.0K sh
Own New
-
Grant·A
Director
—
55.0K sh
Own New
-
Grant·A
Director
—
55.0K sh
Own New
-
Grant·A
File Justin J. KEY
CEO, CFO and Secretary
—
180.0K sh
Own New
-
Grant·A
Director
$0
10.0K sh
Own New
-
Grant·A
Director
$25.4K
10.0K sh · $2.54
Own +127%
-
Grant·A
Director
$0
10.0K sh
Own New
-
Grant·A
Director
$0
20.0K sh
Own New
-
Grant·A
Director
$0
20.0K sh
Own New
-
Grant·A
File Justin J. KEY
Secretary, Acting CEO & CFO
$0
20.0K sh
Own New
-
Grant·A
Director
$0
20.0K sh
Own New
-
Grant·A
Director
$0
20.0K sh
Own New
-
Grant·A
Director
$0
20.0K sh
Own New
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Feb 12, 2026 | File Justin J. KEY | Grant A | 455.0K | — |
| Dec 19, 2025 | Flynn James P | Buy P | 70.0K | $98.0K |
| Dec 18, 2025 | Schornstein Alexander | Sell S | 690.6K | $946.1K |
| Nov 19, 2025 | Flynn James P | Buy P | 12.1K | $22.7K |
| Nov 14, 2025 | File Justin J. KEY | Grant A | 635.0K | — |
| Nov 14, 2025 | Flynn James P | Grant A | 55.0K | — |
| Nov 14, 2025 | DRISCOLL FREDERICK W | Grant A | 55.0K | — |
| Nov 14, 2025 | Riezman Joshua | Grant A | 10.0K | — |
| Nov 14, 2025 | Riezman Joshua | Grant A | 55.0K | — |
| Nov 14, 2025 | Glover Nicholas | Grant A | 55.0K | — |
| Nov 14, 2025 | File Justin J. KEY | Grant A | 180.0K | — |
| Oct 3, 2025 | Lee Charles Benjamin | Grant A | 10.0K | $0 |
| Sep 30, 2025 | Flynn James P | Grant A | 10.0K | $25.4K |
| Aug 8, 2025 | Riezman Joshua | Grant A | 10.0K | $0 |
| Jul 15, 2025 | Glover Nicholas | Grant A | 20.0K | $0 |
| Jul 15, 2025 | Reynolds Thomas C | Grant A | 20.0K | $0 |
| Jul 15, 2025 | File Justin J. KEY | Grant A | 20.0K | $0 |
| Jul 15, 2025 | DRISCOLL FREDERICK W | Grant A | 20.0K | $0 |
| Jul 15, 2025 | Flynn James P | Grant A | 20.0K | $0 |
| Jul 15, 2025 | Wood Steven D | Grant A | 20.0K | $0 |
About MEIP insider trading
This page tracks insider transactions for MEI Pharma, Inc. (MEIP) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.